Today we shared our first quarter financial results & a corporate update. We continued to make strong progress in the first quarter as we executed across our entire portfolio of #PROTAC protein degraders. Read more in our press release. $ARVN #TeamArvinas

Excited to have #TeamArvinas at #ESMOBreast24, showcasing clinical data from our research collaboration with @Pfizer. Together, we're dedicated to innovating for patients in the fight against #BreastCancer. #BCSM

I’m excited to announce Ian Taylor as our new Pres. of R&D and Angela Cacace as our new Chief Scientific Officer at #Arvinas! Read the full press release for more details: rb.gy/tco69m#Leaders… #Innovation #R&D

I’m pleased to welcome Andrew Saik to Arvinas as our new CFO. Andrew’s extensive experience in strategic financial leadership will be invaluable. Welcome to #TeamArvinas, Andrew!

Thanks so much for the great recognition of #TeamArvinas!

Today we shared our Q2 financial results and corporate update. We’re proud of the progress we’ve made as we continue to execute across our portfolio of #PROTAC protein degraders. Read more in our press release below. $ARVN #ArvinasNews

I enjoyed listening to this discussion with our CBO Randy Teel on the future of protein degradation. There is so much more to come for this exciting platform! #PROTAC #Arvinas

Fascinating article on how potential breakthrough technologies have always come with bold statements about their impact. Is AI the next “ big thing”? In the short to medium term there may be some wins but we will have to see if AI can truly deliver the promised impact.

Check out my candid conversation with our Pres. of R&D, Ian Taylor to learn about his career journey, mentors, motivation, and lessons he’s learned along the way. #Arvinas #LeadershipInsights m.youtube.com/watch?v=vBQXsO…

On #BreastCancerResearchDay we celebrate the incredible progress that has been made in #breastcancer research and recognize the need for new advancements. #TeamArvinas is committed to investigating treatment options for breast cancer to improve the lives of patients.

Nice visual explanation of the #ScienceOfPROTAC #Arvinas

So gratifying to see our first fully automated HTS system in place Arvinas! Congrats to the team! #teamarvinas #HTS #proteindegradation

I was recently interviewed by PharmaVoice on the future of protein degradation. #Arvinas

Great review article on #TargetedProteinDegradation in #Neuroscience!

Thanks for the recognition Hartford Business ! #Arvinas

Excited to present and connect with fellow industry leaders at the 7th annual TPD & Induced Proximity Summit next week! Looking forward to sharing insights and exploring innovative ideas together. Let’s make an impact! #TPD

I had an insightful conversation with Angela Cacace our CSO at Arvinas , and learned about her journey in #STEM & leadership in #Neuroscience. I’m excited to share it with you all here: bit.ly/3CMKXFO #TeamArvinas

Today at #SABCS24, we announced with Pfizer Inc. our preliminary Phase 1b data on an investigational treatment combination for locally advanced or metastatic ER+/HER2- breast cancer. Learn more: bit.ly/49w2SNu

Very insightful piece by Noah Berkowitz, the Arvinas CMO

Great advice from Angela Cacace #TeamArvinas #ScienceofPROTAC